Search Results for: Clinical Roundup
-
Clinic Roundup
The study is the first of two identical trials, and the endpoints of both will include vitamin D status, adverse events, physical and clinical laboratory assessments and changes in serum calcium, serum phosphorous and plasma intact parathyroid hormoneBioWorld Today | Friday, September 21, 2012 -
Financings Roundup
Proceeds will be used to fund ACT's clinical activities, including its three ongoing Phase I/II trials for forms of macular degeneration, for development of its other clinical activities and for general corporate purposesBioWorld Today | Friday, September 21, 2012 -
Clinic Roundup
Imprimis Pharmaceuticals Inc., of Solana Beach, Calif., said it started a clinical trial testing Impracor, a topical cream designed to deliver ketoprofenBioWorld Today | Thursday, September 20, 2012 -
Financings Roundup
The company said the financing will enable them to complete a clinical study to confirm the positive treatment effects of Oxabact previously seen in patients with primary hyperoxaluria, a rare inborn autosomal genetic disorder leading to markedly elevated levels of endogenous oxalate in plasma and urineBioWorld Today | Thursday, September 20, 2012 -
Clinic Roundup
The findings were published in the Journal of Clinical OncologyBioWorld Today | Wednesday, September 19, 2012 -
mRNA Cancer Vaccines Score CureVac $105M in Financing
KG, which will enable it to take forward two mRNA-based therapeutic cancer vaccines, in clinical development for prostate cancer and non-small-cell lung cancer (NSCLC...The investment comes in the wake of positive clinical data from early stage trials of both CV9103 and NSCLC vaccine CV9201...The financing adds to more than $4 million in nondilutive funding the company has received from Small Business Innovation Research and other grants.By Cormac Sheridan | BioWorld Today | Wednesday, September 19, 2012 -
Clinic Roundup
No new safety signals emerged in the study, and the overall safety profile of tofacitinib remained consistent with that seen previously in the RA clinical development programBioWorld Today | Tuesday, September 18, 2012 -
Pieces of Federal Funding Puzzle Coming Together
In fact, about a quarter of NIH employees are paid under Title 42, as well as 44 percent of its researchers and clinical practitioners, according to the report...The bill provides some flexibility by allowing up to 50 employees to be paid without regard to the compensation limitation – if the secretary determines the position is vital.By Mari Serebrov | BioWorld Today | Monday, September 17, 2012 -
Pluristem Raising $32M Publicly as PLX Pipeline Gains Attention
Proceeds will be used to support clinical studies, R&D activities and for general corporate purposes, including working capital and administrative expenses...Neuralstem Inc., of Rockville, Md., priced a registered direct offering of 7 million shares at $1 apiece for gross proceeds of $7 million to support working capital, capital expenditures, R&D activities, clinical trials and acquisitions of new technologies or businesses...Valeant also said it intends, subject to market and other conditions, toBy Jennifer Boggs | BioWorld Today | Monday, September 17, 2012 -
Clinic Roundup
The study is designed to assess the clinical impact of the absorption profile of BIOD-123 relative to currently marketed mealtime insulin analogues...The clinical response was durable over 180 days...Glenmark's partner, Paris-based Sanofi SA, has licensed all rights to the drug and is carrying out clinical developmentBioWorld Today | Friday, September 14, 2012 -
Vascular Pharma Makes Splash: Raises $16M, Inks Janssen Deal
We're targeting filing our IND by the second half of 2013, commencing clinical trials thereafter," Shea said...Although our current clinical plan that is funded is specifically to advance the program in diabetic nephropathy, the drug has shown impressive animal results in other diabetic complications, including accelerated atherosclerosis and diabetic retinopathy," Shea said...On Wednesday, Sequenom's shares (NASDAQ:SQNM) gained 28 cents, closing at $3.91.By Catherine Shaffer | BioWorld Today | Thursday, September 13, 2012 -
ICAAC Roundup
Clinical response rates were high across all treatment groups and similar to daptomycinBioWorld Today | Wednesday, September 12, 2012 -
Pharma: Clinic Roundup
Sanofi Pasteur, of Lyon, France, the vaccines division of Sanofi SA, said clinical results published in The Lancet showed the ability of its vaccine candidate to protect against dengue fever caused by three dengue virus typesBioWorld Today | Wednesday, September 12, 2012 -
Financings Roundup
The trial is designed to assess the safety and preliminary efficacy of the Neo-Urinary Conduit in up to 10 patients, as well as to translate the surgical procedure successfully used in preclinical animal models into clinical trials with human patientsBioWorld Today | Wednesday, September 12, 2012 -
Clinic Roundup
The company said those findings, presented at the European Thyroid Association meeting in Pisa, Italy, underscored the feasibility of using local pathology confirmation of ATC in future clinical studiesBioWorld Today | Tuesday, September 11, 2012 -
Financings Roundup
Annovation Biopharma Inc., of Cambridge, Mass., said it raised $8 million in Series A financing led by Atlas Ventures, Partners Innovation Fund and new strategic investor The Medicines Co., of Parsippany, N.J. The funding, which could be expanded to $11 million, is expected to enable preclinical development through clinical proof of concept of the firm's lead, next-generation anesthetic, which is based on technology from Massachusetts General Hospital...Clinical studies are expected to begin in theBioWorld Today | Tuesday, September 11, 2012 -
Financings Roundup
The investment will be used to advance the company's PI3-kinase p110-delta/beta and HDAC6 inhibitor programs through early clinical trials in inflammation and cancerBioWorld Today | Friday, September 7, 2012 -
Clinic Roundup
Laboratorios del Dr. Esteve SA, of Barcelona, Spain, published data from three Phase I trials of S1RA E-52862 in the British Journal of Clinical Pharmacology, showing a favorable safety and pharmacokinetic profile...Omeros Corp., of Seattle, said it filed an investigational new drug application to start clinical studies of OMS824, the lead compound from its phosphodiesterase 10 program for schizophrenia and other cognitive disordersBioWorld Today | Friday, September 7, 2012 -
HHS Looking for an Rx for Costly Clinical Trials
As the cost of conducting clinical trials helps drive drug prices beyond the wallet of many U.S...HHS isn't the only one looking at the cost of clinical trials...The increasing cost of clinical trials has been cited as a big factor in the rising cost of drug development and as a force that's pushing down company valuationsBy Mari Serebrov | BioWorld Today | Friday, September 7, 2012 -
F2G's $30M Round to Support New F3 Antifungal Program
The F3 series was identified through whole-cell screening against clinical Aspergillus fumigatus and Candida albicans...One of the advantages of the infectious disease area is that preclinical models are really predictive of clinical activity," White said...Shares of Repros (NASDAQ:RPRX) gained $1.19, to close Wednesday at $14.23.By Catherine Shaffer | BioWorld Today | Thursday, September 6, 2012
Category
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5476
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.